Description
CJC-1295 with DAC is a long-acting GHRH analogue studied in growth hormone release and endocrine-signalling research. The DAC modification is important in research because it changes how long the compound remains active in pathway models.
Molecular Profile
Molecular Weight: Refer to batch COA
Purity: Per batch COA
Format: Lyophilized white powder
Storage: -20°C, desiccated
Reconstitution: Sterile bacteriostatic water
Research Context
CJC-1295 with DAC is studied in research involving GHRH receptor signalling and extended-duration peptide models. Research teams compare DAC-modified peptides with shorter-acting analogues to evaluate stability, receptor activity, and downstream endocrine pathway responses.
Quality Assurance
Each batch is independently tested for purity, identity, and quality before release. A Certificate of Analysis is available for every lot. All compounds are produced under strict quality control conditions and shipped under appropriate handling protocols from within Canada.
